Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The AZITRAMBA Trial: Azithromycin Treatment for the Airway Microbiome in Asthma

NCT03736629 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT03736629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03736629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The AZITRAMBA Trial: Azithromycin Treatment for the Airway Microbiome in Asthma
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Terminated
Start date
February 1, 2019
Completion date
June 1, 2022
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

asthma chronic